Skip to content

Evaluation of a new technique for drug delivery to the esophageal wall in children with caustic esophageal stricture

Evaluation of the technical and clinical success of a novel endoscopic technique for Mitomycin C application in children with caustic esophageal stricture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612001021864
Enrollment
16
Registered
2012-09-21
Start date
2011-04-06
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

we tried to innovate a new easy safe precise technique for topical mitomycin c application on caustic esophageal stricture aiming for decrease incidence of recuurance of stricture after endoscopic dilatation

Interventions

a new method for endoscopic mitomycin c application on esophageal stricture a) the dose of mitomycin c applied; 5ml (at a concentration of 0.4 mg/ml) b) the number of times applied; 1 to 3 times in 1 month interval " the 2nd and 3rd time will be done only if the child still symptomatic after 1st session" c) the mode of administration; topical application to esophageal stricture using rigid endoscopy and nelaton catheter for drug application d) the approximate duration of this procedure; 15 - 25

a new method for endoscopic mitomycin c application on esophageal stricture a) the dose of mitomycin c applied; 5ml (at a concentration of 0.4 mg/ml) b) the number of times applied; 1 to 3 times in 1 month interval " the 2nd and 3rd time will be done only if the child still symptomatic after 1st session" c) the mode of administration; topical application to esophageal stricture using rigid endoscopy and nelaton catheter for drug application d) the approximate duration of this procedure; 15 - 25 minutes

Sponsors

Ain Shams University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
1 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

caustic esophageal stricture

Exclusion criteria

hypersensitivity to mitomycin c

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026